Barry Flannelly
Director/Board Member presso PROTARA THERAPEUTICS, INC.
Patrimonio netto: 5 M $ in data 31/03/2024
Profilo
Barry P Flannelly is currently an Independent Director at Protara Therapeutics, Inc. and the Executive VP & General Manager-North America at Incyte Corp.
Previously, he served as the Chief Executive Officer at OSS Healthcare, Inc., Director at Genomic Health, Inc., VP-Global Product Strategy & Commercial Planning at Nektar Therapeutics, and Senior Vice President-Commercial at Onyx Pharmaceuticals, Inc. He also worked as a Manager-Pharmacy Services at Johns Hopkins Oncology Center.
Dr. Flannelly holds an undergraduate degree from Massachusetts College of Pharmacy & Health Science, an MBA from the University of Baltimore, and a doctorate from the University of Maryland School of Pharmacy.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INCYTE CORPORATION
0.04% | 14/02/2024 | 85 080 ( 0.04% ) | 5 M $ | 31/03/2024 |
| 07/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Barry Flannelly
| Società | Posizione | Inizio |
|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 01/08/2014 |
| PROTARA THERAPEUTICS, INC. | Director/Board Member | 23/07/2020 |
Precedenti posizioni note di Barry Flannelly
| Società | Posizione | Fine |
|---|---|---|
| GENOMIC HEALTH, INC. | Director/Board Member | 08/11/2019 |
| OSS Healthcare, Inc. | Chief Executive Officer | 01/07/2014 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01/04/2013 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/01/2011 |
| Johns Hopkins Oncology Center | Corporate Officer/Principal | - |
Formazione di Barry Flannelly
| Massachusetts College of Pharmacy & Health Science | Undergraduate Degree |
| University of Baltimore | Masters Business Admin |
| University of Maryland School of Pharmacy | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| PROTARA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
| OSS Healthcare, Inc. | |
| Johns Hopkins Oncology Center |
- Borsa valori
- Insiders
- Barry Flannelly
